首页> 外文期刊>Der Pharmacia Lettre >Carboxymethyl Modification Of Tukhm-Malanga Polyuronide And Its Evaluation For Nanoparticulate Delivery Of Ofloxacin
【24h】

Carboxymethyl Modification Of Tukhm-Malanga Polyuronide And Its Evaluation For Nanoparticulate Delivery Of Ofloxacin

机译:Tukhm-Malanga聚脲醛酸酯的羧甲基修饰及其对氧氟沙星纳米颗粒递送的评价

获取原文
           

摘要

In this study, polyuronide was isolated from Lallementia royleana seeds, and its carboxymethyl modification was carried out by Williamsons’ synthesis. The degree of carboxymethylation substitution was found to be 1.65. The outcomes of the characterization studies performed on carboxymethylated derivative pointed to the increased flow properties and elasticity, decreased swelling property, viscosity and anionic nature. The nanoparticulate suspension of modified polyuronide was prepared by its interaction with chitosan using ofloxacin as a model drug. The concentrations of modified polyuronide and chitosan were found to affect the particle size. The polyelectrolyte nanosuspension formulated using carboxymethylated polyuronide (0.02 %,w/v) and chitosan (0.01%,w/v) showed particle size, polydispersity index, zeta potential and entrapment efficiency of 402.3 nm, 0.315, 22.3 mV and 96.50%, respectively was selected for in vitro release study. The selected batch of nanosuspension provided a sustained release of 87.10% of ofloxacin over a time period of 12 h following first-order kinetics with mechanism of release being diffusion through the matrix.
机译:在这项研究中,从狼尾草种子中分离了聚脲醛酸,并通过威廉姆森斯的合成对其进行了羧甲基修饰。发现羧甲基化取代度为1.65。对羧甲基化衍生物进行的表征研究的结果表明,流动性和弹性增加,溶胀性,粘度和阴离子性质降低。使用氧氟沙星作为模型药物,通过与壳聚糖相互作用,制备了改性聚脲醛酸酯的纳米颗粒悬浮液。发现改性聚脲醛和壳聚糖的浓度会影响粒径。使用羧甲基化聚脲醛酸酯(0.02%,w / v)和壳聚糖(0.01%,w / v)配制的聚电解质纳米悬浮液的粒径,多分散指数,ζ电位和截留效率分别为402.3 nm,0.315、22.3 mV和96.50%。选择用于体外释放研究。选定的一批纳米悬浮液在一级动力学之后的12小时内,提供了氧氟沙星的87.10%持续释放,其释放机理是通过基质扩散。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号